Axoft Raises $55 Million Series A To Advance Clinical Trials For Its Bio-Inspired Brain-Computer Interface
By Amit Chowdhry ● Yesterday at 11:00 PM
Axoft, a neurotechnology company building implantable Brain-Computer Interfaces, has raised an oversubscribed $55 million Series A to expand its clinical trials globally and progress U.S. regulatory approval of its iBCI platform, bringing its total funding to more than $60 million. The round was led by C.P. Group Innovation, with participation from Alumni Ventures, the Stanford President's Venture Fund, Hillhouse Investment, and Gaorong Ventures.